The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
News  >  

Targeted Top 5: Oncology News This Week

Danielle Ternyila
Published Online:1:42 PM, Fri October 5, 2018
Each week, Targeted Oncology reports current advancements in cancer research, including interviews with oncology experts, conference coverage, clinical trial results, and the most recent approvals. Check out our weekly roundup below of the biggest news in oncology that we shared this week.
 
Follow the links below in our infographic to check out the full story.
This week, the FDA announced 2 new approvals for the treatment of patients with multiple myeloma as well as for detecting minimal residual disease in patients with acute lymphoblastic leukemia or multiple myeloma. A roundup of all the FDA news from September 2018 is also now available.
 
During a Targeted Oncology live case-based peer perspectives presentation, Rachel Sanborn, MD, director of Thoracic Oncology, Providence Cancer Center, discussed treatment options for patients with non—small cell lung cancer (NSCLC).
 
In an interview, Javier A. Pinilla-Ibarz, MD, PhD,  a senior member of Moffitt Cancer Center, discussed the current treatment landscape for chronic lymphocytic leukemia, as well as some ongoing research in the field.
 
The top video this week included Fabrice Barlesi, MD, head of the Multidisciplinary Oncology and Therapeutic Innovations Department at Aix-Marseille University and the Assistance Publique Hôpitaux de Marseille, France, where he discussed the importance of molecular testing in patients with NSCLC.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.